Professional
Added to YB: 2026-06-22
Pitch date: 2026-03-31
2359.HK [bullish]
WuXi AppTec Co., Ltd.
Author Info
No bio for this author
Company Info
WuXi AppTec Co., Ltd., an investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs in the People’s Republic of China, the United States, Europe, and internationally.
Market Cap
CNY 309.6B
Pitch Price
N/A
Price Target
235.00
Dividend
1.88%
EV/EBITDA
12.44
P/E
15.93
EV/Sales
5.93
Sector
Life Sciences Tools and Services
Category
growth
Baron Emerging Markets Fund New Position: WuXi AppTec Co., Ltd.
2359.HK (new position): World's largest CRDMO for small molecules & new modalities. Moat: scale, FDA execution, cost edge hard to replicate outside China. BIOSECURE fears overdone; clients retained, backlog compounding. GLP-1 obesity super-cycle + oligo pillar drives mid-to-high-teens EPS CAGR. Trades at discount to peers; stock could 2x+ in 5yrs.
Read full article (1 min)